A Randomized, Blinded, Placebo-controlled, Phase II Trial of LEE011 in Patients With Relapsed, Refractory, Incurable Teratoma With Recent Progression

Mise à jour : Il y a 4 ans
Référence : NCT02300987

Femme et Homme

Extrait

To assess the efficacy of LEE011 compared to placebo in patients with relapsed/refractory teratoma with recent progression


Critère d'inclusion

  • Teratoma